Tandem Diabetes Care Inc (TNDM)
30.74
+0.59
(+1.96%)
USD |
NASDAQ |
Nov 21, 16:00
30.72
-0.02
(-0.07%)
After-Hours: 20:00
Tandem Diabetes Care Enterprise Value: 1.855B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.855B |
| November 19, 2024 | 1.706B |
| November 18, 2024 | 1.764B |
| November 15, 2024 | 1.671B |
| November 14, 2024 | 1.753B |
| November 13, 2024 | 1.824B |
| November 12, 2024 | 1.918B |
| November 11, 2024 | 1.935B |
| November 08, 2024 | 1.885B |
| November 07, 2024 | 2.063B |
| November 06, 2024 | 2.124B |
| November 05, 2024 | 2.050B |
| November 04, 2024 | 2.033B |
| November 01, 2024 | 1.971B |
| October 31, 2024 | 1.934B |
| October 30, 2024 | 1.999B |
| October 29, 2024 | 2.037B |
| October 28, 2024 | 2.025B |
| October 25, 2024 | 1.933B |
| October 24, 2024 | 1.960B |
| October 23, 2024 | 1.986B |
| October 22, 2024 | 2.077B |
| October 21, 2024 | 2.114B |
| October 18, 2024 | 2.195B |
| October 17, 2024 | 2.160B |
| Date | Value |
|---|---|
| October 16, 2024 | 2.337B |
| October 15, 2024 | 2.344B |
| October 14, 2024 | 2.328B |
| October 11, 2024 | 2.309B |
| October 10, 2024 | 2.248B |
| October 09, 2024 | 2.443B |
| October 08, 2024 | 2.492B |
| October 07, 2024 | 2.618B |
| October 04, 2024 | 2.618B |
| October 03, 2024 | 2.531B |
| October 02, 2024 | 2.578B |
| October 01, 2024 | 2.571B |
| September 30, 2024 | 2.659B |
| September 27, 2024 | 2.675B |
| September 26, 2024 | 2.781B |
| September 25, 2024 | 2.818B |
| September 24, 2024 | 2.870B |
| September 23, 2024 | 2.869B |
| September 20, 2024 | 2.817B |
| September 19, 2024 | 2.805B |
| September 18, 2024 | 2.687B |
| September 17, 2024 | 2.714B |
| September 16, 2024 | 2.691B |
| September 13, 2024 | 2.774B |
| September 12, 2024 | 2.760B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
717.62M
Minimum
Nov 10 2023
9.420B
Maximum
Dec 28 2021
4.047B
Average
3.498B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 141.52B |
| Masimo Corp | 9.446B |
| RxSight Inc | 1.569B |
| Perspective Therapeutics Inc | 150.86M |
| Xtant Medical Holdings Inc | 85.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.25M |
| Revenue (Quarterly) | 243.97M |
| Total Expenses (Quarterly) | 270.06M |
| EPS Diluted (Quarterly) | -0.35 |
| Gross Profit Margin (Quarterly) | 51.09% |
| Profit Margin (Quarterly) | -9.53% |
| Earnings Yield | -6.28% |
| Normalized Earnings Yield | -6.233 |